Xiuning Le

12.2k citations
223 papers · 8.3k · 15 hit papers · h-index 44

Impact in

    • Lung Cancer Treatments and Mutations
    • Lung Cancer Diagnosis and Treatment
  • Oncology top 1%
    • Cancer Immunotherapy and Biomarkers
    • HER2/EGFR in Cancer Research
    • Lung Cancer Research Studies

Papers in

    • Lung Cancer Treatments and Mutations 161
    • Lung Cancer Diagnosis and Treatment 14
    • Brain Metastases and Treatment 9
    • Cancer Immunotherapy and Biomarkers 20
    • Lung Cancer Research Studies 7
    • HER2/EGFR in Cancer Research 5

Xiuning Le

197 papers receiving 8.1k citations

Xiuning Le's Hit Papers

The changing treatment landscape of EGFR-mutant non-small-cell lung cancer 2024 · 92 citations
920+2+5Years since publication200400600

Peers

Xiuning Le
Comparison fields: 5 of 116
  • Pulmonary and Respiratory Medicine 4.4k
  • Oncology 2k
  • Cancer Research 509
  • Health Informatics 86
  • Otorhinolaryngology 94
Replace Tina Cascone with:
Tina Cascone United States
Ferdinandos Skoulidis United States
Phuoc T. Tran United States
David Liu United States
Helena Alexandra Yu United States
Collin Michael Blakely United States
Pankaj Vats United States
Philip Jonsson United States
Niki Karachaliou Spain
Tao Jiang China
Xiuning Le relative to Tina Cascone United States Tina Cascone's profile →
Citations per field
00.5×1.7×
Tina Cascone · 1×
Citations per year

Countries citing papers authored by Xiuning Le

Since Specialization
Citations

This map shows the geographic impact of Xiuning Le's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiuning Le with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiuning Le more than expected).

Fields of papers citing papers by Xiuning Le

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiuning Le. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiuning Le. The network helps show where Xiuning Le may publish in the future.

Co-authors

The 25 scholars most cited alongside Xiuning Le, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Xiuning Le Line = papers co-authored together Xiuning Le links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 223 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Tepotinib in Non–Small-Cell Lung Cancer with MET Exon 14 Skipping Mutations
Hit paper breakdown →
2020661
2
Neoadjuvant nivolumab or nivolumab plus ipilimumab in operable non-small cell lung cancer: the phase 2 randomized NEOSTAR trial
Hit paper breakdown →
2021494
3
Molecular Mechanisms and Future Implications of VEGF/VEGFR in Cancer Therapy
Hit paper breakdown →
2022354
4
Structure-based classification predicts drug response in EGFR-mutant NSCLC
Hit paper breakdown →
2021350
5
Landscape of EGFR-Dependent and -Independent Resistance Mechanisms to Osimertinib and Continuation Therapy Beyond Progression in EGFR -Mutant NSCLC
Hit paper breakdown →
2018338
6
Pan-cancer T cell atlas links a cellular stress response state to immunotherapy resistance
Hit paper breakdown →
2023311
7 2020260
8
Oncogene-specific differences in tumor mutational burden, PD-L1 expression, and outcomes from immunotherapy in non-small cell lung cancer
Hit paper breakdown →
2021233
9 2020216
10 2019190
11
AI in drug discovery and its clinical relevance
Hit paper breakdown →
2023183
12
Neoadjuvant chemotherapy plus nivolumab with or without ipilimumab in operable non-small cell lung cancer: the phase 2 platform NEOSTAR trial
Hit paper breakdown →
2023173
13 2007161
14
Stereotactic ablative radiotherapy with or without immunotherapy for early-stage or isolated lung parenchymal recurrent node-negative non-small-cell lung cancer: an open-label, randomised, phase 2 trial
Hit paper breakdown →
2023154
15 2020153
16 2020143
17 2021130
18
CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors
Hit paper breakdown →
2024121
19 2016113
20 2017111

About Xiuning Le

Xiuning Le is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Otorhinolaryngology, Cancer Research and Radiology, Nuclear Medicine and Imaging, having authored 223 papers that have together received 8.3k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (161 papers), Cancer Immunotherapy and Biomarkers (20 papers), Lung Cancer Diagnosis and Treatment (14 papers), Brain Metastases and Treatment (9 papers), Head and Neck Cancer Studies (7 papers), Lung Cancer Research Studies (7 papers), Radiomics and Machine Learning in Medical Imaging (6 papers) and HER2/EGFR in Cancer Research (5 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (4.4k citations), Oncology (2k citations), Cancer Research (509 citations), Health Informatics (86 citations) and Otorhinolaryngology (94 citations). Xiuning Le has collaborated with scholars based in United States, China and Japan. Frequent co-authors include John Victor Heymach, Monique B. Nilsson, Tina Cascone, Sonia A. Patel, Rakesh K. Jain, Jianjun J. Zhang, Lingzhi Hong, Daniel Botelho Costa, Jonathan Wade Goldman and Niamh Coleman. Their work appears in journals such as Journal of Thoracic Oncology, Annals of Oncology, Clinical Cancer Research, Cancers and ESMO Open.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact